Director/PDMR Shareholding
Source: RNS
26 September 2024
BARONSMEAD SECOND VENTURE TRUST PLC
("THE COMPANY")
The Company was notified on 25 September that Graham McDonald, Non-executive Director of the Company, acquired 1,595 Ordinary shares of 10 pence each in the capital of the Company, through participation in the Company's Dividend Reinvestment Plan, at a price of 57.60 pence per Ordinary share. As a result of this purchase, Mr McDonald's aggregate holding of shares in the Company is 54,749 Ordinary shares, representing 0.01% of the Company's issued share capital.
|
1. |
Details of PDMR / person closely associated with them ("PCA") |
||
|
a) |
Name |
Graham McDonald |
|
|
2. |
Reason for the notification |
||
|
b) |
Position / status |
Non-Executive Director |
|
|
c) |
Initial notification / amendment |
Initial Notification |
|
|
3. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||
|
a) |
Name |
Baronsmead Second Venture Trust plc |
|
|
b) |
LEI |
2138008D3WUMF6TW8C28 |
|
|
4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||
|
a) |
Description of the financial instrument
Identification Code |
Ordinary Shares of £0.10 each
ISIN: GB0030028103 |
|
|
b) |
Nature of the transaction |
Acquisition of shares through participation in the Dividend Reinvestment Plan |
|
|
c) |
Price(s) and volume(s) |
Price(s) |
Volume(s) |
|
£0.5760 |
1,595 |
||
|
d) |
Aggregated information Aggregated volume Price |
N/A - single transaction |
|
|
e) |
Date of the transaction |
17/09/2024 |
|
|
f) |
Place of the transaction |
London Stock Exchange (XLON) |
|
For further information please contact:
Baronsmead VCT Investor Relations
020 7382 0999
baronsmeadvcts@greshamhouse.com
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
